IP Library Granted Patent US 10,011,556
Granted Patent B2
US 10,011,556 · App. 15/226,766 · Granted Jul 3, 2018

Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis

Inventors: Kelly Forest (Honolulu, HI); Jeremy Forest (Honolulu, HI); Jakob Bredsguard (Lake Forest, CA); Travis Thompson (Anaheim, CA)
Assignee: Biosynthetic Technologies, LLC
C07C69/604C07C67/347C07C69/602C07C69/67C07C69/675C10M105/04C10M105/36C10M105/42C10M107/32C10M177/00C08G63/06C10M2207/281C10M2207/282C10M2207/2825C10M2207/301C10M2209/1023C10N2220/024C10N2230/02C10N2230/10C10N2230/64C10N2270/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,011,556
App. No.
15/226,766
Granted
Jul 3, 2018
Kind
B2
Abstract

Provided herein are estolide base oils and oligomeric compounds prepared from processes that include cross metathesis. Exemplary processes include the preparation of terminally-unsaturated fatty acids by cross metathesis, and the subsequent oligomerization of terminally-unsaturated fatty acids to provide estolide compounds, such as the process set forth below:

Claims (23)

1. A compound of Formula I:

wherein

x is, independently for each occurrence, an integer selected from 0 to 20;

y is, independently for each occurrence, an integer selected from 0 to 20;

n is an integer equal to or greater than 0;

R 1 is an optionally substituted, branched or unbranched alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is selected from hydrogen and an optionally substituted C 2 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched,

wherein each fatty acid chain residue of said at least one compound is independently optionally substituted, and wherein, for at least one fatty acid chain residue, x is an integer selected from 7 and 8 and y is an integer selected from 1, 2, 3, 4, 5, and 6.

2. The compound according to claim 1 , wherein x is selected from 7 and 8 for each occurrence.

3. The compound according to claim 1 , wherein R 1 an optionally substituted C 1 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched.

4. The compound according to claim 1 , wherein each fatty acid chain residue is unsubstituted.

5. The compound according to claim 4 , wherein n is selected from 0 to 20.

6. The compound according to claim 5 , wherein R 1 an unsubstituted C 7 to C 17 alkyl that is saturated and branched or unbranched.

7. The compound according to claim 6 , wherein R 1 is unbranched.

8. The compound according to claim 6 , wherein R 2 an unsubstituted C 1 to C 22 alkyl that is saturated, and branched or unbranched.

9. The compound according to claim 8 , wherein R 2 is a branched C 6 to C 12 alkyl.

10. The compound of claim 4 , wherein R 1 is a C 9 to C 16 alkyl that is unsubstituted and unbranched.

11. The compound of claim 10 , wherein x is selected from 7 and 8 for each occurrence.

12. The compound of claim 11 , wherein y is selected from 1, 2, 3, 4, 5, and 6 for each occurrence.

13. The compound of claim 12 , wherein R 1 is saturated.

14. The compound of claim 13 , wherein R 2 is an unsubstituted C 2 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched.

15. The compound of claim 14 , wherein R 2 is saturated.

16. The compound of claim 4 , wherein R 2 is an unsubstituted C 2 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched.

Assignments (2)
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: BP TECHNOLOGY VENTURES INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045688/0600 →
SECURITY INTEREST Recorded Jan 30, 2018
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: BP TECHNOLOGY VENTURES INC.
Reel/Frame 045196/0587 →
Continuity (6)
Continuation 14937738 · Nov 10, 2015
Continuation 14026387 · Sep 13, 2013
Continuation 13707480 · Dec 6, 2012
Provisional Application 61577598 · Dec 19, 2011
Provisional Application 61610376 · Mar 13, 2012
Related Publication 20170057905A1 · Mar 2, 2017